These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Saturation assays of radioligand binding to receptors and their allosteric modulatory sites. Basile A Curr Protoc Neurosci; 2001 May; Chapter 7():Unit7.6. PubMed ID: 18428532 [TBL] [Abstract][Full Text] [Related]
14. Methods for the determination of the specific radioactivity of radioligands. Bürgisser E J Recept Res; 1984; 4(1-6):357-69. PubMed ID: 6098661 [TBL] [Abstract][Full Text] [Related]
15. Calculating specific binding for prolactin receptor assays. Brooks CL; Leinen JG; DeSombre ER; Jensen EV Mol Cell Endocrinol; 1982 Apr; 26(1-2):81-94. PubMed ID: 6282673 [TBL] [Abstract][Full Text] [Related]
16. 'Optimal' designs for drug, neurotransmitter and hormone receptor assays. Dunn G Stat Med; 1988 Jul; 7(7):805-15. PubMed ID: 2841743 [TBL] [Abstract][Full Text] [Related]
17. Characterization of the vasoactive intestinal peptide receptor in rat submandibular gland: radioligand binding assay in membrane preparations. Turner JT; Bylund DB J Pharmacol Exp Ther; 1987 Sep; 242(3):873-81. PubMed ID: 2821229 [TBL] [Abstract][Full Text] [Related]
18. High throughput fluorescence polarization: a homogeneous alternative to radioligand binding for cell surface receptors. Allen M; Reeves J; Mellor G J Biomol Screen; 2000 Apr; 5(2):63-9. PubMed ID: 10803605 [TBL] [Abstract][Full Text] [Related]
19. Use of scintillation proximity assay to measure radioligand binding to immobilized receptors without separation of bound from free ligand. Berry J; Price-Jones M; Killian B Methods Mol Biol; 2012; 897():79-94. PubMed ID: 22674161 [TBL] [Abstract][Full Text] [Related]